A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- a meta-analysis of 31 studies

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Kedzior, Karina K ^a   Laeber, Lisa T ^a  

^a JACOBS UNIVERSITY BREMEN   (Germany)

Author keywords

Anxiety disorders; Cannabis use; Cannabis use disorders (dependence, abuse); Meta analysis; Systematic review

Indexed keywords

ANXIETY DISORDER; ARTICLE; CANNABIS USE; COHORT ANALYSIS; COMORBIDITY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FOLLOW UP; HUMAN; MEDLINE; META ANALYSIS (TOPIC); PSYCINFO; ADOLESCENT; ADULT; ANXIETY DISORDERS; CANNABIS SMOKING; FEMALE; MALE; MARIJUANA ABUSE; META ANALYSIS; PROSPECTIVE STUDY; YOUNG ADULT;

CANNABIS;

ADOLESCENT; ADULT; ANXIETY DISORDERS; CANNABIS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84901461322     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-14-136     Document Type: Article

References (75)

1. Grobe T. Gesundheitsreport 2012 2012, Techniker Krankenkasse: Hamburg, Germany.
2. Wittchen H-U, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen H-C. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011, 21:655-679. 10.1016/j.euroneuro.2011.07.018, 21896369.
3. Kessler RC, Angermeyer M, Anthony JC, DEG R, Demyttenaere K, Gasquet I, DEG G, Gluzman S, Gureje O, Haro JM, Kawakami N, Karam A, Levinson D, Medina Mora ME, Oakley Browne MA, Posada-Villa J, Stein DJ, Adley Tsang CH, Aguilar-Gaxiola S, Alonso J, Lee S, Heeringa S, Pennell BE, Berglund P, Gruber MJ, Petukhova M, Chatterji S, Ustun TB. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007, 6:168-176. 2174588, 18188442.
4. Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ, He JP, Koretz D, McLaughlin KA, Petukhova M, Sampson NA, Zaslavsky AM, Merikangas KR. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry 2012, 69:372-380. 10.1001/archgenpsychiatry.2011.160, 3445020, 22147808.
5. Australian Bureau of Statistics The National Survey of Mental Health and Wellbeing (cat. no. 4326.0) 2007, Australia: ABS, Australian Bureau of Statistics.
6. Degenhardt L, Chiu W-T, Sampson N, Kessler RC, Anthony JC, Angermeyer M, Bruffaerts R, de Girolamo G, Gureje O, Huang Y, Karam A, Kostyuchenko S, Lepine JP, Mora MEM, Neumark Y, Ormel JH, Pinto-Meza A, Posada-Villa J, Stein DJ, Takeshima T, Wells JE. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the WHO World Mental Health Surveys. PLoS Med 2008, 5:e141. 10.1371/journal.pmed.0050141, 2443200, 18597549.
7. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012, 379:55-70. 10.1016/S0140-6736(11)61138-0, 22225671.
8. Degenhardt L, Ferrari AJ, Calabria B, Hall WD, Norman RE, McGrath J, Flaxman AD, Engell RE, Freedman GD, Whiteford HA, Vos T. The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: Results from the GBD 2010 Study. PLoS ONE 2013, 8:0076635.
9. Degenhardt L, Hall WD, Lynskey M, McGrath J, McLaren J, Calabria B, Whiteford H, Vos T. Should burden of disease estimates include cannabis use as a risk factor for psychosis?. PLoS Med 2009, 6:29.
10. Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental heath outcomes: A systematic review. Lancet 2007, 370:319-328. 10.1016/S0140-6736(07)61162-3, 17662880.
11. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol (Oxf) 2005, 19:187-194.
12. Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry 2011, 68:555-561. 10.1001/archgenpsychiatry.2011.5, 21300939.
13. Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 2010, 36:1115-1130. 10.1093/schbul/sbp031, 2963055, 19386576.
14. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003, 98:1493-1504. 10.1046/j.1360-0443.2003.00437.x, 14616175.
15. Kedzior K, Martin-Iverson M. Association between severity of cannabis dependence and depression. Psychology 2010, 1:233-237.
16. Crippa JA, Zuardi AW, Martín-Santos R, Bhattacharyya S, Atakan Z, McGuire P, Fusar-Poli P. Cannabis and anxiety: A critical review of the evidence. Hum Psychopharmacol 2009, 24:515-523. 10.1002/hup.1048, 19693792.
17. Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Allebeck P. Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts. BMC Psychiatry 2012, 12:12-112. 10.1186/1471-244X-12-12, 3298500, 22339984.
18. Leweke FM, Koethe D. Cannabis and psychiatric disorders: It is not only addiction. Addict Biol 2008, 13:264-275. 10.1111/j.1369-1600.2008.00106.x, 18482435.
19. Peters EN, Budney AJ, Carroll KM. Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction 2012, 107:1404-1417. 10.1111/j.1360-0443.2012.03843.x, 3377777, 22340422.
20. Moylan S, Jacka FN, Pasco JA, Berk M. Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies. BMC Med 2012, 10:123. 10.1186/1741-7015-10-123, 3523047, 23083451.
21. Moffitt TE, Harrington H, Caspi A, Kim-Cohen J, Goldberg D, Gregory AM, Poulton R. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry 2007, 64:651-660. 10.1001/archpsyc.64.6.651, 17548747.
22. Smith JP, Randall CL. Anxiety and alcohol use disorders: comorbidity and treatment considerations. Alcohol Res 2012, 34:414-431. 3860396, 23584108.
23. Wilson N, Cadet JL. Comorbid mood, psychosis, and marijuana abuse disorders: A theoretical review. J Addict Dis 2009, 28:309-319. 10.1080/10550880903182960, 2922015, 20155601.
24. Hall W, Lynskey M. The challenges in developing a rational cannabis policy. Curr Opin Psychiatry 2009, 22:258-262. 10.1097/YCO.0b013e3283298f36, 19293714.
25. Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J 2009, 339:b2535.
26. Agosti V, Nunes E, Levin F. Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse 2002, 28:643-652. 10.1081/ADA-120015873, 12492261.
27. Beard JR, Dietrich UC, Brooks LO, Brooks RT, Heathcote K, Kelly B. Incidence and outcomes of mental disorders in a regional population: the Northern Rivers Mental Health Study. Aust N Z J Psychiatry 2006, 40:674-682. 10.1080/j.1440-1614.2006.01867.x, 16866763.
28. Brook J, Cohen P, Brook D. Longitudinal study of co-occurring psychiatric disorders and substance use. J Am Acad Child Adolesc Psychiatry 1998, 37:322-330. 10.1097/00004583-199803000-00018, 9519638.
29. Brook JS, Rosen Z, Brook DW. The effect of early marijuana use on later anxiety and depressive symptoms. NYS Psychologist 2001, 13:35-40.
30. Buckner JD, Schmidt NB, Lang AR, Small JW, Schlauch RC, Lewinsohn PM. Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. J Psychiatr Res 2008, 42:230-239. 10.1016/j.jpsychires.2007.01.002, 2254175, 17320907.
31. Buckner JD, Schmidt NB. Marijuana effect expectancies: Relations to social anxiety and marijuana use problems. Addict Behav 2008, 33:1477-1483. 10.1016/j.addbeh.2008.06.017, 2556243, 18694625.
32. Buckner JD, Joiner TE, Schmidt NB, Zvolensky MJ. Daily marijuana use and suicidality: The unique impact of social anxiety. Addict Behav 2012, 37:387-392. 10.1016/j.addbeh.2011.11.019, 3288149, 22154236.
33. Cascone P, Zimmermann G, Auckenthaler B, Robert-Tissot C. Cannabis dependence in Swiss adolescents: Exploration of the role of anxiety, coping styles, and psychosocial difficulties. Swiss J Psychol 2011, 70:129-139.
34. Chabrol H, Ducongé E, Casas C, Roura C, Carey KB. Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology. Addict Behav 2005, 30:829-840. 10.1016/j.addbeh.2004.08.027, 15833585.
35. Chabrol H, Chauchard E, Girabet J. Cannabis use and suicidal behaviours in high-school students. Addict Behav 2008, 33:152-155. 10.1016/j.addbeh.2007.04.029, 17537584.
36. Cheung JTW, Mann RE, Ialomiteanu A, Stoduto G, Chan V, Ala-Leppilampi K, Rehm J. Anxiety and mood disorders and cannabis use. Am J Drug Alcohol Abuse 2010, 36:118-122. 10.3109/00952991003713784, 20337509.
37. Cougle JR, Bonn-Miller MO, Vujanovic AA, Zvolensky MJ, Hawkins KA. Posttraumatic stress disorder and cannabis use in a nationally representative sample. Psychol Addict Behav 2011, 25:554-558.
38. Crum RM, Anthony JC. Cocaine use and other suspected risk factors for obsessive-compulsive disorder: a prospective study with data from the Epidemiologic Catchment Area surveys. Drug Alcohol Depend 1993, 31:281-295. 10.1016/0376-8716(93)90010-N, 8462416.
39. Degenhardt L, Hall W, Lynskey M. The relationship between cannabis use, depression and anxiety among Australian adults: Findings from the National Survey of Mental Health and Well-Being. Soc Psychiatry Psychiatr Epidemiol 2001, 36:219-227. 10.1007/s001270170052, 11515699.
40. Degenhardt L, Coffey C, Carlin JB, Swift W, Moore E, Patton GC. Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia. Br J Psychiatry 2010, 196:290-295. 10.1192/bjp.bp.108.056952, 20357305.
41. Degenhardt L, Coffey C, Romaniuk H, Swift W, Carlin JB, Hall WD, Patton GC. The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction 2013, 108:124-133. 10.1111/j.1360-0443.2012.04015.x, 22775447.
42. Fergusson DM, Lynskey MT, Horwood LJ. The short-term consequences of early onset cannabis use. J Abnorm Child Psychol 1996, 24:499-512. 10.1007/BF01441571, 8886945.
43. Hayatbakhsh MR, Najman JM, Jamrozik K, Mamun AA, Alati R, Bor W. Cannabis and anxiety and depression in young adults: A large prospective study. J Am Acad Child Adolesc Psychiatry 2007, 46:408-417. 10.1097/chi.0b013e31802dc54d, 17314727.
44. Lamers CTJ, Bechara A, Rizzo M, Ramaekers JG. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. J Psychopharmacol (Oxf) 2006, 20:302-311.
45. Low NC, Lee SS, Johnson JG, Williams JB, Harris ES. The association between anxiety and alcohol versus cannabis abuse disorders among adolescents in primary care settings. Fam Pract 2008, 25:321-327. 10.1093/fampra/cmn049, 18753288.
46. Martins S, Gorelick D. Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. population. Drug Alcohol Depend 2011, 119:28-36. 10.1016/j.drugalcdep.2011.05.010, 3179836, 21641123.
47. McGee R, Williams S, Poulton R, Moffitt T. A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction 2000, 95:491-503. 10.1046/j.1360-0443.95.12s4.4.x, 10829326.
48. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. Br Med J 2002, 325:1195-1198.
49. Roberts RE, Roberts CR, Xing Y. Comorbidity of substance use disorders and other psychiatric disorders among adolescents: Evidence from an epidemiologic survey. Drug Alcohol Depend 2007, 88S:S4-S13.
50. Swift W, Coffey C, Carlin JB, Degenhardt L, Patton GC. Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood. Addiction 2008, 103:1361-1370. 10.1111/j.1360-0443.2008.02246.x, 18855826.
51. van der Pol P, Liebregts N, de Graaf R, Ten Have M, Korf D, van den Brink W, van Laar M. Mental health differences between frequent cannabis users with and without dependence and the general population. Addiction 2013, 10.1111/add.12196.
52. van Laar M, van Dorsselaer S, Monshouwer K, de Graaf R. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?. Addiction 2007, 102:1251-1260. 10.1111/j.1360-0443.2007.01875.x, 17624975.
53. Wittchen H-U, Fröhlich C, Behrendt S, Günther A, Rehm J, Zimmermann P, Lieb R, Perkonigg A. Cannabis use and cannabis use disorders and their relationship to mental disorders: A 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007, 88:S60-S70.
54. Zvolensky MJ, Bernstein A, Sachs-Ericsson N, Schmidt NB, Buckner JD, Bonn-Miller MO. Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample. J Psychiatr Res 2006, 40:477-486. 10.1016/j.jpsychires.2005.09.005, 16271364.
55. Zvolensky MJ, Cougle JR, Johnson KA, Bonn-Miller MO, Bernstein A. Marijuana use and panic psychopathology among a representative sample of adults. Exp Clin Psychopharmacol 2010, 18:129-134. 2917792, 20384424.
56. Schmidt C, Kohlmann T. When to use the odds ratio or the relative risk?. Int J Public Health 2008, 53:165-167. 10.1007/s00038-008-7068-3, 19127890.
57. Borenstein M, Hedges L, Higgins J, Rothstein H. Introduction to meta-analysis 2009, John Wiley & Sons, Ltd: Great Britain.
58. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
59. Rosenthal J. Qualitative descriptors of strength of association and effect size. J Soc Serv Res 1996, 21:37-59.
60. Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in a meta-analyses. Br Med J 2003, 327:557-560.
61. Rosenthal R. The 'file drawer' problem and tolerance for null results. Psychol Bull 1979, 86:638-641.
62. Sterne J, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001, 54:1046-1055. 10.1016/S0895-4356(01)00377-8, 11576817.
63. Duval S, Tweedie R. A nonparametric 'trim and fill' method of accounting for publication bias in meta-analysis. J Am Statist Assoc 2000, 95:89-98.
64. Begg C, Mazumdar M. Operating characterstics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101. 10.2307/2533446, 7786990.
65. Egger M, Davey S, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. Br Med J 1997, 315:629-634.
66. Carter M, Fisher C, Isaac M. Recovery from comorbidity. SAGE Open 2013, 3:1-14.
67. McNamee R. Confounding and confounders. Occup Environ Med 2003, 60:227-234. 10.1136/oem.60.3.227, 1740493, 12598677.
68. Shapiro S. Causation, bias and confounding: a hitchhiker's guide to the epidemiological galaxy. Part 1. Principles of causality in epidemiological research: time order, specification of the study base and specificity. J Fam Plann Reprod Health Care 2008, 34:83-87.
69. Solowij N, Pesa N. Cognitive abnormalities and cannabis use. Rev Bras Psiquiatr 2010, 32(Suppl 1):S31-S40.
70. Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, Bruffaerts R, de Girolamo G, de Graaf R, Gureje O, Haro JM, Karam EG, Kessler RC, Kovess V, Lane MC, Lee S, Levinson D, Ono Y, Petukhova M, Posada-Villa J, Seedat S, Wells JE. Worldwide use of mental health services for anxiety, mood, and substance disorders: Results from 17 countries in the WHO World Mental Health (WMH) Surveys. Lancet 2007, 370:841-850. 10.1016/S0140-6736(07)61414-7, 2847360, 17826169.
71. van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug Alcohol Depend 2013, 133:352-359. 10.1016/j.drugalcdep.2013.06.009, 23886472.
72. Schulte SJ, Meier PS, Stirling J. Dual diagnosis clients' treatment satisfaction - a systematic review. BMC Psychiatry 2011, 11:64. 10.1186/1471-244X-11-64, 3101156, 21501510.
73. Kedzior K, Badcock J, Martin-Iverson M. Validity and consistency of self-reports regarding substance use in general research volunteers, including regular cannabis users and schizophrenia patients. Subst Use Misuse 2006, 41:743-750. 10.1080/10826080500411502, 16603458.
74. Large M, Smith G, Sara G, Paton M, Kedzior K, Nielssen O. Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings. Int J Meth Psych Res 2012, 21:134-148.
75. van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Facilitators and barriers in treatment seeking for cannabis dependence. Drug Alcohol Depend 2013, 133:776-780. 10.1016/j.drugalcdep.2013.08.011, 24035185.